Recent publications


Reaction Biology Corporation (“RBC”) is a premier provider of in vitro enzyme activity assays for HTS and profiling. Serving over 300 customers worldwide, we specialize in optimizing nanoliter scale assaying methods, allowing for high quality data with fast turnaround and economical pricing. RBC offers gold-standard radioisotope based assays in the Kinase, Methyltransferase, and HAT enzyme classes, as well as full suite of HDAC/SIRT assays. RBC also now provides an expanding line of active, human recombinant HMTs, including some exclusive complexes. Compound libraries, custom assay development, discovery partnerships and cell-based assays are also part of our portfolio of services. Please contact us at 877-347-2368 or sales@reactionbiology.com for any inquiries.

3rd Epigenetics in Drug Discovery, Boston, MA, May 8-10, 2013
More >

Targeting Epigenetic Regulators for Cancer Therapy, New York City, NY, May 24th, 2013
More >

Next Generation Kinase Inhibitors, June 17-19, Boston, MA
More >


EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
More >

Histone deacetylase inhibitors in the treatment of cancer: overview and perspectives
More >

HDAC3-selective inhibitor enhances extinction of cocaine-seeking behavior in a persistent manner
More >